Company intelligence / Profile preview

OncoLead

Karlsfeld, Bavaria, Germanyoncolead.com ↗

Ownership: Private
Employees: ~4
Development stage: Other

Overview

OncoLead provides in vitro cellular screening using large panels of human cancer cell lines to help pharmaceutical, biotech companies, and academic labs accelerate anticancer drug discovery. Their standardized processes deliver reproducible results within 2–6 weeks. They have screened over 10,000 compounds—including known anticancer agents—and offer data analysis/consulting to interpret results in the context of reference profiles[1][2][3].

Therapeutic areas: Oncology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on OncoLead.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoLead.

Explore the full profile